Table 2.
Characteristic | Study Participants, No. (%)a | P Valuec | ||
---|---|---|---|---|
Total (n = 214)b | LTBI (n = 120) | No LTBI (n = 94) | ||
Age, median (IQR), y | 62 (56–70) | 63 (57–68) | 61 (55–72) | .26 |
Male sex | 148 (69) | 86 (72) | 62 (66) | .37 |
Race/ethnicity | .25 | |||
Hispanic | 205 (96) | 115 (96) | 90 (96) | |
White | 3 (1) | 3 (3) | 0 | |
African American | 1 (1) | 0 | 1 (1) | |
Asian | 5 (2) | 2 (2) | 3 (3) | |
Region of residence | .41 | |||
Lima | 162 (76) | 90 (75) | 72 (77) | |
Coast other than Lima | 27 (13) | 18 (15) | 9 (10) | |
Highlands | 12 (6) | 7 (6) | 5 (5) | |
Amazons | 13 (6) | 5 (4) | 8 (9) | |
Hypertension | 138 (65) | 76 (63) | 62 (66) | .69 |
Diabetes mellitus | 83 (39) | 45 (38) | 38 (40) | .66 |
Dyslipidemia | 85 (40) | 49 (41) | 36 (38) | .71 |
End-stage renal disease | 6 (3) | 4 (3) | 2 (2) | .60 |
History of cancer | 11 (5) | 6 (5) | 5 (5) | .93 |
History of immunosuppression | 1 (1) | 0 | 1 (1) | .26 |
Tobacco use | 65 (30) | 41 (34) | 24 (26) | .17 |
BMI, median (IQR), kg/m2 | 26.3 (23.9–29.8) | 26.9 (24.7–29.4) | 25.5 (23.5–30.4) | .13 |
Obesity (BMI ≥30 kg/m2) | 50 (23) | 25 (21) | 25 (27) | .38 |
Family history of CAD | .70 | |||
No | 123 (58) | 68 (57) | 55 (59) | |
Yes | 82 (38) | 48 (40) | 34 (36) | |
Unknown | 9 (4) | 4 (3) | 5 (5) | |
History of incarceration | 10 (5) | 4 (3) | 6 (6) | .29 |
History of any tuberculosis contact | 52 (24) | 30 (25) | 22 (23) | .79 |
History of LTBI | 4 (2) | 3 (3) | 1 (1) | .44 |
Healthcare worker | 19 (9) | 10 (8) | 9 (10) | .75 |
Abbreviations: BMI, body mass index; CAD, coronary artery disease; IQR, interquartile range; LTBI, latent tuberculosis infection.
aData represent No. (%) of study participants unless otherwise specified.
bOne of the 215 study participants had an indeterminate quantiFERON-TB test result; therefore, 214 participants were included in this analysis.
cThe χ2 test was used for categorical variables, and the Mann-Whitney test for numeric variables.